• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FREE PSA IMMUNOASSAY; TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FREE PSA IMMUNOASSAY; TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA Back to Search Results
Catalog Number ASKU
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/06/2017
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(4).
 
Event Description
The customer stated that they received questionable results for one patient sample tested for multiple assays on the cobas 6000 e 601 module (e601).Of the questioned results, there were erroneous results for the following assays: elecsys ft3 iii (ft3), the elecsys ft4 ii assay (ft4), the elecsys tsh assay (tsh), the elecsys myoglobin immunoassay (myo), elecsys ferritin (ferr), the elecsys free psa immunoassay (fpsa), and the elecsys cortisol test system (cort).It was asked, but it is not known if the erroneous results were reported outside of the laboratory.Roche markets the following myo assays: elecsys myoglobin immunoassay and elecsys myoglobin stat immunoassay.It was asked, but it is not known which myo assay was used for sample testing.Roche markets the following cort assays: elecsys cortisol test system and elecsys cortisol ii.It was asked, but it is not known which cort assay was used for sample testing.The sample was collected on (b)(6) 2017 and tested on the e601 and abbott analyzers on 07/06/2017 and 07/11/2017.The customer believes that the sample may contain an interferent which interferes with the roche assays.An additional myo value of 21.30 ug/ml was provided.It could not be clarified if this was an additional myo value from the patient sample, or if it was provided in error.A clarification has been requested.The cort results were measured after one freeze/thaw cycle of the sample.This medwatch will apply to the fpsa assay.Refer to the following manufacturer report reference numbers for information related to the ft3, ft4, and tsh assays: (b)(4).Refer to the medwatches with the following a1.Patient identifiers for information related to the myo, ferr, and cort assays: pt-(b)(6) = fpsa, pt-(b)(6) = ferr, pt-(b)(6) = cort.No adverse events were alleged to have occurred with the patient.The serial number of the e601 analyzer used at the customer site was (b)(4).
 
Manufacturer Narrative
The patient has hypertension, type 2 diabetes, asthma, and gout.
 
Manufacturer Narrative
It has been confirmed that the myo value of 21.30 ug/ml was provided in error.Samples from the patient were provided for investigation.The samples were found to contain an interfering factor to the streptavidin used in the roche assays.This limitation is covered in product labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FREE PSA IMMUNOASSAY
Type of Device
TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6776733
MDR Text Key83750538
Report Number1823260-2017-01654
Device Sequence Number0
Product Code MTG
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
P000027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 09/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/13/2017
Initial Date FDA Received08/09/2017
Supplement Dates Manufacturer Received07/13/2017
07/13/2017
Supplement Dates FDA Received08/13/2017
09/05/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age67 YR
-
-